BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3088115)

  • 1. Phagocytosis by human monocytes of unopsonized particulate activators of the human alternative complement pathway: induction by cytokine.
    Chakravarti B; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1986 Aug; 137(3):880-6. PubMed ID: 3088115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional discrimination by human monocytes between their C3b receptors and their recognition units for particulate activators of the alternative complement pathway.
    Czop JK; Austen KF
    J Immunol; 1980 Jul; 125(1):124-8. PubMed ID: 7381198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
    Johnson E; Eskeland T; Bertheussen K
    Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway.
    Czop JK; Austen KF
    J Immunol; 1985 Apr; 134(4):2588-93. PubMed ID: 2579146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytes.
    Czop JK; Fearon DT; Austen KF
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3831-5. PubMed ID: 278997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1).
    Bohnsack JF; O'Shea JJ; Takahashi T; Brown EJ
    J Immunol; 1985 Oct; 135(4):2680-6. PubMed ID: 3161946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
    Czop JK; Austen KF
    J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on phagocytosis of unopsonized rabbit erythrocytes by human monocytes.
    Chakravarti B
    Cell Immunol; 1988 May; 113(2):251-60. PubMed ID: 2834070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of de novo protein synthesis by human mononuclear leukocytes in opsonin-independent phagocytosis.
    Chakravarti B; Chakravarti DN; Müller-Eberhard HJ
    Cell Immunol; 1994 Mar; 154(1):134-42. PubMed ID: 8118882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes.
    Pommier CG; Inada S; Fries LF; Takahashi T; Frank MM; Brown EJ
    J Exp Med; 1983 Jun; 157(6):1844-54. PubMed ID: 6854210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of soluble yeast beta-glucans that inhibit human monocyte phagocytosis mediated by beta-glucan receptors.
    Janusz MJ; Austen KF; Czop JK
    J Immunol; 1986 Nov; 137(10):3270-6. PubMed ID: 3021849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of phagocytosis by a specific fibronectin fragment that links particulate activators to the fibronectin adherence receptor of human monocytes.
    Czop JK; Austen KF
    J Immunol; 1982 Dec; 129(6):2678-81. PubMed ID: 6292296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonin-independent phagocytosis of activators of the alternative complement pathway by human monocytes.
    Czop JK; Fearon DT; Austen KF
    J Immunol; 1978 Apr; 120(4):1132-8. PubMed ID: 641341
    [No Abstract]   [Full Text] [Related]  

  • 14. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators.
    Williams JD; Czop JK; Austen KF
    J Immunol; 1984 Jun; 132(6):3034-40. PubMed ID: 6327815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).
    Arnaout MA; Todd RF; Dana N; Melamed J; Schlossman SF; Colten HR
    J Clin Invest; 1983 Jul; 72(1):171-9. PubMed ID: 6874946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human fibronectin is an opsonin for IgG antibody-coated sheep erythrocytes.
    Cosio FG
    J Lab Clin Med; 1984 Apr; 103(4):613-9. PubMed ID: 6699476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the opsonic and monocyte adherence functions of the specific fibronectin fragment that enhances phagocytosis of particulate activators.
    Czop JK; Kadish JL; Zepf DM; Austen KF
    J Immunol; 1985 Mar; 134(3):1844-50. PubMed ID: 3968434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.
    Leijh PC; van den Barselaar MT; van Zwet TL; Daha MR; van Furth R
    J Clin Invest; 1979 Apr; 63(4):772-84. PubMed ID: 374424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of leukotrienes by human monocytes upon stimulation of their beta-glucan receptor during phagocytosis.
    Czop JK; Austen KF
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2751-5. PubMed ID: 2986134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
    Schlesinger LS; Horwitz MA
    J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.